의료 상호 운용성(Healthcare Interoperability) 솔루션 시장조사 보고서

출판 : MarketsandMarkets (마켓츠앤마켓츠)   출판년월 : 2023년04월

의료 상호 운용성(Healthcare Interoperability) 솔루션 시장 : 유형 [소프트웨어(EHR, 실험실 시스템, 이미징, 의료 정보 교환, 엔터프라이즈), 서비스], 상호 운용성 수준(기초, 구조, 의미론), 최종 사용자, 지역별 – 2027년까지의 세계 예측
Healthcare Interoperability Solutions Market by Type (Software (EHR, Lab System, Imaging, Health Information Exchange, Enterprises), and Services), Interoperability Level (Foundational, Structural, Semantic), End User, and Region – Global Forecast to 2027

리포트목차　　　　주문/문의　　　　납기/라이센스안내

The global healthcare interoperability solutions market is projected to reach USD 6.2 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 12.9% during the forecast period. Growth in this market is driven by the increased demand for efficient & cost-effective healthcare delivery, government funding for healthcare interoperability, and the rapid adoption of EHR.
글로벌 의료 상호 운용성 솔루션 시장은 예측 기간 동안 연평균 12.9% 성장하여 2022년 34억 달러에서 2027년까지 62억 달러에 이를 것으로 예상됩니다. 이 시장의 성장은 효율적이고 비용 효율적인 의료 제공에 대한 수요 증가, 의료 상호 운용성을 위한 정부 자금 지원, EHR의 빠른 채택에 의해 주도됩니다.

However, the lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period.

“HIE Interoperability Solutions was the fastest-growing segment in the type of healthcare interoperability solutions market for software solutions in 2021”
HIE Interoperability Solutions accounted for the largest share of healthcare interoperability solutions market for software solutions in 2021. The large share of this segment can be attributed to the associated benefits such as improved patient safety by reducing medication and medical errors, increased efficiency by eliminating unnecessary paperwork and handling, as well as providing caregivers with clinical decision support tools for more effective care and treatment.

“Foundational Interoperability accounted for the largest segment by level of interoperaility in the healthcare interoperability solutions market in 2021”
Based on the level of interoperability, the foundational interoperability segment accounted for the largest share of the global healthcare interoperability solutions market. The large share of the foundational interoperability segment can be attributed to the need for safe and accurate data exchange across disparate systems as well as the growing demand for cost-effective basic-level interoperability.

“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives to unfold new national interoperability policies and rework existing policies with public and private healthcare organizations, growing medical tourism, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
• By Designation – C-level: 50%, Director-level: 35%, and Others: 15%
• By Region – North America: 48%, Europe: 32%, Asia Pacific: 15%, and Rest of the World: 5%.

Key players in the Healthcare interoperability solutions Market
The key players operating in the healthcare interoperability solutions market include Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).

Research Coverage:
The report analyzes the healthcare interoperability solutions market and aims at estimating the market size and future growth potential of various market segments, based on type, level of interoperability, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Analysis of key drivers (increasing demand for efficient and cost-effective healthcare delivery, government initiatives and regulations to enhance patient care and safety, emergence of new medical technologies, growing adoption of electronic health records), restraints (lack of accurate interoperability solutions across healthcare supply chain, lack of standards and protocols in IT businesses, use of outdated legacy systems in hospitals and clinic chains), opportunities (growing markets for healthcare interoperability solutions in developing countries, advancements in software technology for real-time data exchange),and challenges (increasing complexity due to lack of consistent data, shortage of skilled healthcare IT professionals, patient data security and privacy concerns in healthcare industry)influencing the growth of the healthcare interoperability solutions market.
 Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare interoperability solutions market.
 Market Development: Comprehensive information on the lucrative emerging markets, type, level of interoperability, end user, and region.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare interoperability solutions market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare interoperability solutions market like Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands).

목차

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.2.2 MARKETS COVERED 30
FIGURE 1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION 30
1.2.3 YEARS CONSIDERED 31
1.3 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 32
1.5 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH APPROACH 33
FIGURE 2 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 35
2.1.2.1 Primary sources 35
2.1.2.2 Key data from primary sources 36
2.1.2.3 Insights from primary experts 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 38
FIGURE 5 CAGR PROJECTIONS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 40
2.2.1 TOP-DOWN APPROACH 40
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 6 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET RANKING ANALYSIS 43
2.5 STUDY ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 44
2.6.1 METHODOLOGY-RELATED LIMITATIONS 44
2.6.2 SCOPE-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 44
2.8 IMPACT OF ECONOMIC RECESSION ON HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 45
2.8.1 IMPACT OF RUSSIA–UKRAINE WAR 45
2.8.2 IMPACT OF INFLATION 45
3 EXECUTIVE SUMMARY 46
FIGURE 7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 46
FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2022 VS. 2027 (USD MILLION) 47
FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2022 VS. 2027 (USD MILLION) 48
FIGURE 10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 49
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 50
4 PREMIUM INSIGHTS 52
4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW 52
FIGURE 12 GOVERNMENT INITIATIVES FOR ENHANCED PATIENT CARE AND SAFETY TO DRIVE MARKET 52
4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE AND COUNTRY (2021) 53
FIGURE 13 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2021 53
4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 54
FIGURE 14 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 54
4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2022–2027) 54
FIGURE 15 NORTH AMERICA TO DOMINATE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET DURING FORECAST PERIOD 54
4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2022 VS. 2027 55
FIGURE 16 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 17 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 57
5.2.1.1 Increasing demand for efficient and cost-effective healthcare delivery 57
5.2.1.2 Government initiatives and regulations to enhance patient care and safety 57
5.2.1.3 Emergence of new medical technologies 58
5.2.1.4 Growing adoption of electronic health records 59
5.2.2 RESTRAINTS 59
5.2.2.1 Lack of accurate interoperability solutions across healthcare supply chain 59
5.2.2.2 Lack of standards and protocols in IT businesses 60
5.2.2.3 Use of outdated legacy systems in hospitals and clinic chains 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growing markets for healthcare interoperability solutions in developing countries 61
5.2.3.2 Advancements in software technology for real-time data exchange 62
5.2.4 CHALLENGES 63
5.2.4.1 Increasing complexity due to lack of consistent data 63
5.2.4.2 Shortage of skilled healthcare IT professionals 64
5.2.4.3 Patient data security and privacy concerns in healthcare industry 64
5.3 PRICING ANALYSIS 65
5.4 VALUE CHAIN ANALYSIS 66
FIGURE 18 VALUE CHAIN ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 67
5.5 ECOSYSTEM ANALYSIS 68
FIGURE 19 ECOSYSTEM ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 68
5.6 TECHNOLOGY ANALYSIS 68
5.6.1 APPLICATION PROGRAMMING INTERFACES 68
5.6.2 CLOUD-BASED SOLUTIONS 68
5.6.3 BLOCKCHAIN TECHNOLOGY 68
5.6.4 FAST HEALTHCARE INTEROPERABILITY RESOURCES 69
5.6.5 ARTIFICIAL INTELLIGENCE 69
5.6.6 MACHINE LEARNING 69
5.7 KEY CONFERENCES AND EVENTS IN 2023 69
TABLE 2 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023 69
5.8 REGULATORY ANALYSIS 70
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
5.8.2 LAWS, REGULATIONS, AND STANDARDS 72
TABLE 7 KEY REGULATIONS AND STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY 72
5.9 PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 20 PORTER’S FIVE FORCES ANALYSIS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 73
TABLE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 74
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 74
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 74
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%) 75
5.10.2 BUYING CRITERIA 75
FIGURE 22 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 75
TABLE 10 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 75
6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE 76
6.1 INTRODUCTION 77
TABLE 11 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 77
6.2 SOFTWARE SOLUTIONS 77
TABLE 12 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 13 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 79
6.2.1 EHR INTEROPERABILITY SOLUTIONS 79
6.2.1.1 Large installation base of EHR systems to ensure single and continuous readable documents for physicians 79
TABLE 14 EHR INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 80
TABLE 15 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS 81
6.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost market 81
TABLE 16 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 82
TABLE 17 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
6.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS 83
6.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market 83
TABLE 18 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 84
TABLE 19 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.2.4 HIE INTEROPERABILITY SOLUTIONS 85
6.2.4.1 Large investments by federal governments to propel market 85
TABLE 20 HIE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 85
TABLE 21 HIE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
6.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS 86
6.2.5.1 Advancing software technology and rising demand for expanded care delivery to augment market 86
TABLE 22 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 87
TABLE 23 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS 87
TABLE 24 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 88
TABLE 25 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
6.3 SERVICES 89
6.3.1 INCREASING ADOPTION OF HEALTHCARE IT INTEGRATION SERVICES BY PROVIDERS TO AUGMENT MARKET 89
TABLE 26 SERVICES OFFERED BY KEY PLAYERS 90
TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 91
7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL 92
7.1 INTRODUCTION 93
TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 93
7.2 FOUNDATIONAL INTEROPERABILITY 93
7.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO FUEL MARKET 93
TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.3 STRUCTURAL INTEROPERABILITY 94
7.3.1 STRUCTURAL INTEROPERABILITY TO ENSURE INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT DATA FIELD LEVEL 94
TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.4 SEMANTIC INTEROPERABILITY 96
7.4.1 SEMANTIC INTEROPERABILITY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 96
TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 97
8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER 98
8.1 INTRODUCTION 99
TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 99
8.2 HEALTHCARE PROVIDERS 99
TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION) 101
8.2.1 HOSPITALS & CLINICS 101
8.2.1.1 Increasing patient volume and rising need to reduce errors in data management to augment market 101
TABLE 35 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
8.2.2 LONG-TERM CARE CENTERS 103
8.2.2.1 Increasing number of care centers and need to maintain compliance with medical reforms to propel market 103
TABLE 36 LONG-TERM CARE CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
8.2.3 DIAGNOSTIC & IMAGING CENTERS 104
8.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market 104
TABLE 37 DIAGNOSTIC & IMAGING CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
8.2.4 OTHER HEALTHCARE PROVIDERS 105
TABLE 38 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
8.3 HEALTHCARE PAYERS 106
8.3.1 ADOPTION OF HEALTHCARE INTEROPERABILITY BY PAYERS TO DECREASE HOSPITAL STAYS AND REPEAT TESTS 106
TABLE 39 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION) 107
8.4 PHARMACIES 107
8.4.1 PHARMACIES TO USE HEALTHCARE INFORMATION EXCHANGE SOLUTIONS FOR INDIVIDUALIZED PATIENT CARE AND SUPPORT 107
TABLE 40 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION) 108
9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION 109
9.1 INTRODUCTION 110
TABLE 41 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 110
9.2 NORTH AMERICA 110
FIGURE 23 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT 112
TABLE 42 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 43 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 44 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 45 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 114
TABLE 46 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 114
TABLE 47 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 114
9.2.1 US 115
9.2.1.1 Growing need to curtail healthcare costs to drive market 115
TABLE 48 US: KEY MACROINDICATORS 116
TABLE 49 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 50 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 51 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 117
TABLE 52 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 118
TABLE 53 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 118
9.2.2 CANADA 118
9.2.2.1 Increasing healthcare digitization to support market 118
TABLE 54 CANADA: KEY MACROINDICATORS 119
TABLE 55 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 56 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 57 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 120
TABLE 58 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 121
TABLE 59 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 121
9.3 EUROPE 121
TABLE 60 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 61 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 62 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 63 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 124
TABLE 64 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 124
TABLE 65 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 124
9.3.1 GERMANY 125
9.3.1.1 Modernized healthcare system and increased healthcare expenditure to augment market 125
TABLE 66 GERMANY: KEY MACROINDICATORS 126
TABLE 67 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 68 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 69 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 127
TABLE 70 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 127
TABLE 71 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 127
9.3.2 UK 128
9.3.2.1 Government initiatives and NHS programs to drive demand 128
TABLE 72 UK: KEY MACROINDICATORS 129
TABLE 73 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 74 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 75 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 130
TABLE 76 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 130
TABLE 77 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 130
9.3.3 FRANCE 131
9.3.3.1 Government measures to curtail healthcare expenditures to fuel market 131
TABLE 78 FRANCE: KEY MACROINDICATORS 131
TABLE 79 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 80 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 81 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 132
TABLE 82 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
TABLE 83 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 133
9.3.4 ITALY 133
9.3.4.1 Increasing government initiatives in HCIT technology implementation to aid market 133
TABLE 84 ITALY: KEY MACROINDICATORS 134
TABLE 85 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 86 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 87 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 135
TABLE 88 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 135
TABLE 89 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 136
9.3.5 NETHERLANDS 136
9.3.5.1 Robust healthcare infrastructure and eHealth initiatives to propel market 136
TABLE 90 NETHERLANDS: KEY MACROINDICATORS 137
TABLE 91 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 92 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 93 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 138
TABLE 94 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 138
TABLE 95 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 138
9.3.6 REST OF EUROPE 139
TABLE 96 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 97 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 98 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 140
TABLE 99 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 141
TABLE 100 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 141
9.4 ASIA PACIFIC 141
FIGURE 24 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT 142
TABLE 101 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 143
TABLE 102 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 103 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 104 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 144
TABLE 105 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 144
TABLE 106 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 144
9.4.1 JAPAN 145
9.4.1.1 Japan to be largest healthcare interoperability market in Asia Pacific during forecast period 145
TABLE 107 JAPAN: KEY MACROINDICATORS 145
TABLE 108 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 109 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 110 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 146
TABLE 111 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 146
TABLE 112 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 147
9.4.2 AUSTRALIA 147
9.4.2.1 Increasing government initiatives for better clinical communication to drive market 147
TABLE 113 AUSTRALIA: KEY MACROINDICATORS 147
TABLE 114 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 115 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 116 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 148
TABLE 117 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 149
TABLE 118 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 149
9.4.3 REST OF ASIA PACIFIC 149
TABLE 119 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 120 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 121 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 151
TABLE 122 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 151
TABLE 123 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 151
9.5 LATIN AMERICA 152
9.5.1 IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET 152
TABLE 124 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 125 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 126 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 153
TABLE 127 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 154
TABLE 128 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 154
9.6 MIDDLE EAST & AFRICA 154
9.6.1 INCREASED ESTABLISHMENT OF NEW HOSPITALS TO DRIVE MARKET 154
TABLE 129 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 130 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 131 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 156
TABLE 132 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 156
TABLE 133 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 156
10 COMPETITIVE LANDSCAPE 157
10.1 INTRODUCTION 157
10.2 KEY STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 157
TABLE 134 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY DEVELOPMENTS (JANUARY 2019–MARCH 2023) 158
10.3 MARKET RANKING OF KEY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 159
FIGURE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: MARKET RANKING OF KEY PLAYERS (2022) 159
10.4 MARKET SHARE ANALYSIS 160
10.4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 160
TABLE 135 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2021 161
10.5 COMPETITIVE EVALUATION QUADRANT FOR KEY PLAYERS 161
10.5.1 STARS 161
10.5.2 EMERGING LEADERS 161
10.5.3 PERVASIVE PLAYERS 162
10.5.4 PARTICIPANTS 162
FIGURE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2022) 162
10.6 COMPETITIVE EVALUATION QUADRANT FOR START-UPS/SMES 163
10.6.1 PROGRESSIVE COMPANIES 163
10.6.2 DYNAMIC COMPANIES 163
10.6.3 STARTING BLOCKS 163
10.6.4 RESPONSIVE COMPANIES 163
FIGURE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2022) 164
10.7 COMPETITIVE BENCHMARKING 165
10.7.1 PRODUCT FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 165
TABLE 136 COMPANY PRODUCT FOOTPRINT 165
10.7.2 REGIONAL FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 166
TABLE 137 COMPANY REGION FOOTPRINT 166
10.7.3 FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 167
TABLE 138 COMPANY FOOTPRINT 167

10.8 COMPETITIVE SCENARIO 168
10.8.1 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS 168
TABLE 139 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2019–2022 168
10.8.2 KEY DEALS 169
TABLE 140 KEY DEALS, 2019–2022 169
11 COMPANY PROFILES 171
11.1 KEY PLAYERS 171
(Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View)*
11.1.1 ORACLE HEALTH 171
TABLE 141 ORACLE HEALTH: COMPANY OVERVIEW 171
FIGURE 28 ORACLE HEALTH: COMPANY SNAPSHOT (2021) 172
11.1.2 EPIC SYSTEMS CORPORATION 175
TABLE 142 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 175
11.1.3 INFOR, INC. 177
TABLE 143 INFOR, INC.: COMPANY OVERVIEW 177
FIGURE 29 INFOR, INC.: COMPANY SNAPSHOT (2019) 177
11.1.4 INTERSYSTEMS CORPORATION 180
TABLE 144 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW 180
11.1.5 KONINKLIJKE PHILIPS N.V. 184
TABLE 145 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 184
FIGURE 30 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 185
11.1.6 VERADIGM LLC 187
TABLE 146 VERADIGM LLC: COMPANY OVERVIEW 187
FIGURE 31 VERADIGM LLC: COMPANY SNAPSHOT (2021) 188
11.1.7 COGNIZANT 191
TABLE 147 COGNIZANT: COMPANY OVERVIEW 191
FIGURE 32 COGNIZANT: COMPANY SNAPSHOT (2021) 192
11.1.8 CHANGE HEALTHCARE 194
TABLE 148 CHANGE HEALTHCARE: COMPANY OVERVIEW 194
FIGURE 33 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021) 194
11.1.9 NEXTGEN HEALTHCARE, INC. 196
TABLE 149 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW 196
FIGURE 34 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020) 196
11.1.10 MERATIVE 198
TABLE 150 MERATIVE: COMPANY OVERVIEW 198
11.1.11 MEDICAL INFORMATION TECHNOLOGY, INC. 199
TABLE 151 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW 199
FIGURE 35 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019) 200
11.1.12 LYNIATE 201
TABLE 152 LYNIATE: COMPANY OVERVIEW 201

11.1.13 OSP LABS 203
TABLE 153 OSP LABS: COMPANY OVERVIEW 203
11.1.14 ORION HEALTH GROUP OF COMPANIES 204
TABLE 154 ORION HEALTH GROUP OF COMPANIES: COMPANY OVERVIEW 204
FIGURE 36 ORION HEALTH GROUP OF COMPANIES: COMPANY SNAPSHOT (2021) 205
11.1.15 ONYX TECHNOLOGY LLC 206
TABLE 155 ONYX TECHNOLOGY LLC: COMPANY OVERVIEW 206
11.2 OTHER PLAYERS 207
11.2.1 VISOLVE 207
TABLE 156 VISOLVE: COMPANY OVERVIEW 207
11.2.2 JITTERBIT 208
TABLE 157 JITTERBIT: COMPANY OVERVIEW 208
11.2.3 INTERFACEWARE INC. 209
TABLE 158 INTERFACEWARE INC.: COMPANY OVERVIEW 209
11.2.4 VIRTUSA CORP. 210
TABLE 159 VIRTUSA CORP.: COMPANY OVERVIEW 210
FIGURE 37 VIRTUSA CORP.: COMPANY SNAPSHOT (2020) 210
11.2.5 CONSENSUS CLOUD SOLUTIONS INC. 212
TABLE 160 CONSENSUS CLOUD SOLUTIONS INC.: COMPANY OVERVIEW 212
11.2.6 MPHRX 213
11.2.7 WIPRO 214
11.2.8 EMIDS 215
11.2.9 NALASHAA 216
11.2.10 DEEVITA LLC 216
* Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX 217
12.1 DISCUSSION GUIDE 217
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220
12.3 CUSTOMIZATION OPTIONS 222
12.4 RELATED REPORTS 222
12.5 AUTHOR DETAILS 223